These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 19307977

  • 1. Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis.
    Tahara T, Arisawa T, Shibata T, Nakamura M, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Takahama K, Watanabe M, Yamashita H, Hirata I.
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):613-9. PubMed ID: 19307977
    [Abstract] [Full Text] [Related]

  • 2. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T, Arisawa T, Shibata T, Wang FY, Nakamura M, Sakata M, Nagasaka M, Takagi T, Kamiya Y, Fujita H, Nakamura M, Hasegawa S, Iwata M, Takahama K, Watanabe M, Hirata I, Nakano H.
    Digestion; 2007 Jun; 75(1):54-61. PubMed ID: 17438355
    [Abstract] [Full Text] [Related]

  • 3. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection.
    Park SY, Yoo EJ, Cho NY, Kim N, Kang GH.
    J Pathol; 2009 Dec; 219(4):410-6. PubMed ID: 19639607
    [Abstract] [Full Text] [Related]

  • 4. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.
    Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I, Arisawa T.
    Digestion; 2010 Dec; 82(1):27-36. PubMed ID: 20150736
    [Abstract] [Full Text] [Related]

  • 5. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
    Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H.
    Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
    [Abstract] [Full Text] [Related]

  • 6. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation.
    Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS.
    Am J Pathol; 2003 Oct; 163(4):1551-6. PubMed ID: 14507661
    [Abstract] [Full Text] [Related]

  • 7. Chronic nonsteroidal anti-inflammatory drug (NSAID) use suppresses multiple CpG islands hyper methylation (CIHM) of tumor suppressor genes in the human gastric mucosa.
    Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Okubo M, Hirata I, Arisawa T.
    Cancer Sci; 2009 Jul; 100(7):1192-7. PubMed ID: 19432886
    [Abstract] [Full Text] [Related]

  • 8. Helicobacter pylori induces promoter hypermethylation and downregulates gene expression of IRX1 transcription factor on human gastric mucosa.
    Guo XB, Guo L, Zhi QM, Ji J, Jiang JL, Zhang RJ, Zhang JN, Zhang J, Chen XH, Cai Q, Li JF, Yan M, Gu QL, Liu BY, Zhu ZG, Yu YY.
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1685-90. PubMed ID: 21649733
    [Abstract] [Full Text] [Related]

  • 9. Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis.
    Shin CM, Kim N, Jung Y, Park JH, Kang GH, Kim JS, Jung HC, Song IS.
    Cancer Sci; 2010 Jun; 101(6):1337-46. PubMed ID: 20345486
    [Abstract] [Full Text] [Related]

  • 10. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk.
    Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):989-95. PubMed ID: 16467114
    [Abstract] [Full Text] [Related]

  • 11. The relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis.
    Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Hasegawa S, Takagi T, Wang FY, Hirata I, Nakano H.
    Int J Mol Med; 2007 Jan 01; 19(1):143-8. PubMed ID: 17143558
    [Abstract] [Full Text] [Related]

  • 12. E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis.
    Miyazaki T, Murayama Y, Shinomura Y, Yamamoto T, Watabe K, Tsutsui S, Kiyohara T, Tamura S, Hayashi N.
    Helicobacter; 2007 Oct 01; 12(5):523-31. PubMed ID: 17760721
    [Abstract] [Full Text] [Related]

  • 13. CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas.
    Alves MK, Lima VP, Ferrasi AC, Rodrigues MA, De Moura Campos Pardini MI, Rabenhorst SH.
    APMIS; 2010 Apr 01; 118(4):297-307. PubMed ID: 20402675
    [Abstract] [Full Text] [Related]

  • 14. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk.
    Kaise M, Yamasaki T, Yonezawa J, Miwa J, Ohta Y, Tajiri H.
    Helicobacter; 2008 Feb 01; 13(1):35-41. PubMed ID: 18205664
    [Abstract] [Full Text] [Related]

  • 15. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
    Kyzekové J, Arlt J, Arltová M.
    Hepatogastroenterology; 2001 Feb 01; 48(38):594-602. PubMed ID: 11379362
    [Abstract] [Full Text] [Related]

  • 16. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M.
    Clin Cancer Res; 2006 May 15; 12(10):2995-3002. PubMed ID: 16707594
    [Abstract] [Full Text] [Related]

  • 17. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
    Oue N, Motoshita J, Yokozaki H, Hayashi K, Tahara E, Taniyama K, Matsusaki K, Yasui W.
    J Pathol; 2002 Sep 15; 198(1):55-9. PubMed ID: 12210063
    [Abstract] [Full Text] [Related]

  • 18. Role of Helicobacter pylori in chronic gastritis: a prospective study.
    Kudo M, Asaka M, Kato M, Katagiri M, Kagaya H, Nishikawa K, Koshiyama T, Hokari K, Meguro T, Takeda H.
    J Clin Gastroenterol; 1995 Sep 15; 21 Suppl 1():S174-8. PubMed ID: 8775014
    [Abstract] [Full Text] [Related]

  • 19. Histological and clinical predictive value of determination of tissue CagA status by PCR in Helicobacter pylori infected patients; results of the large population based study in western Turkey.
    Saruç M, Demir MA, Küçükmetin N, Kandiloglu AR, Akarca US, Yüceyar H.
    Hepatogastroenterology; 2002 Sep 15; 49(45):878-81. PubMed ID: 12064012
    [Abstract] [Full Text] [Related]

  • 20. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N.
    Aliment Pharmacol Ther; 2004 Jul 15; 20 Suppl 1():25-32. PubMed ID: 15298602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.